Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dugo, Matteo"'
Autor:
El Bezawy R; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Percio S; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., De Cesare M; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Colella G; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, 20132, Milan, Italy., Veneroni S; Biomarkers Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Doldi V; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Martini S; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Baratti D; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Kusamura S; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Deraco M; Peritoneal Surface Malignancies Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy., Gandellini P; Department of Biosciences, University of Milan, 20133, Milan, Italy., Zaffaroni N; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy. nadia.zaffaroni@istitutotumori.mi.it., Zuco V; Molecular Pharmacology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133, Milan, Italy.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2022 Oct; Vol. 29 (10), pp. 1394-1404. Date of Electronic Publication: 2022 Mar 29.
Autor:
Colombo C; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy., Minna E; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargiuli C; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Muzza M; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Dugo M; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Department of Applied Research and Technology Development, Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pogliaghi G; Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy., Tosi D; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Bulfamante G; Department of Health Sciences, Division of Human Pathology, Università degli Studi di Milano, Milan, Italy., Greco A; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fugazzola L; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. laura.fugazzola@unimi.it.; Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy. laura.fugazzola@unimi.it., Borrello MG; Department of Research, Molecular Mechanisms Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. MariaGrazia.Borrello@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Nov 16; Vol. 39 (1), pp. 245. Date of Electronic Publication: 2020 Nov 16.
Autor:
Vergani E; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy., Cossa M; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Frigerio S; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Di Guardo L; Unit of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gallino G; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mattavelli I; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vergani B; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy., Lalli L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Tamborini E; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Valeri B; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargiuli C; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy., Shahaj E; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Ferrarini M; Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy., Ferrero E; Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy., Gomez Lira M; Biology and Genetics, Department of Neurosciences Biomedicine and Movement Sciences, University of Verona, Verona, Italy., Huber V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Del Vecchio M; Unit of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sensi M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy., Leone BE; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy., Santinami M; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Rodolfo M; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Vallacchi V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. viviana.vallacchi@istitutotumori.mi.it.
Publikováno v:
Cell communication and signaling : CCS [Cell Commun Signal] 2020 Sep 23; Vol. 18 (1), pp. 156. Date of Electronic Publication: 2020 Sep 23.
Autor:
Profumo V; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Forte B; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Percio S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Rotundo F; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Doldi V; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Ferrari E; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Fenderico N; Oncode Institute and Department of Cell Biology, Centre for Molecular Medicine, University Medical Centre Utrecht, Utrecht, 3584 CX, The Netherlands., Dugo M; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Romagnoli D; Centre for Integrative Biology, University of Trento, Trento, 38123, Italy., Benelli M; Centre for Integrative Biology, University of Trento, Trento, 38123, Italy., Valdagni R; Department of Oncology and Hemato-oncology, University of Milan, Milan, 20133, Italy.; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy.; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Dolfini D; Department of Biosciences, University of Milan, Milan, 20133, Italy., Zaffaroni N; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Gandellini P; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy. paolo.gandellini@istitutotumori.mi.it.
Publikováno v:
Nature communications [Nat Commun] 2019 Jan 18; Vol. 10 (1), pp. 307. Date of Electronic Publication: 2019 Jan 18.
Autor:
Huber V; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vallacchi V; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Fleming V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Hu X; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Cova A; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Dugo M; Platform of Integrated Biology., Shahaj E; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Sulsenti R; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vergani E; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Filipazzi P; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., De Laurentiis A; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Lalli L; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Di Guardo L; Medical Oncology Unit 1, and., Patuzzo R; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Vergani B; Microscopy and Image Analysis Consortium, Università degli Studi di Milano-Bicocca, Monza, Italy., Casiraghi E; Department of Computer Science 'Giovanni Degli Antoni,' Università degli Studi di Milano, Milan, Italy., Cossa M; Molecular Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Gualeni A; Molecular Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Bollati V; EPIGET-Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy., Arienti F; Immunohematology and Transfusion Medicine, and., De Braud F; Medical Oncology Unit 1, and., Mariani L; Medical Statistics, Biometry and Bioinformatics, Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Villa A; Microscopy and Image Analysis Consortium, Università degli Studi di Milano-Bicocca, Monza, Italy., Altevogt P; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany., Rodolfo M; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy., Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Dec 03; Vol. 128 (12), pp. 5505-5516. Date of Electronic Publication: 2018 Nov 05.
Autor:
Dugo M; Functional Genomic and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: matteo.dugo@istitutotumori.mi.it., Huang X; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. Electronic address: drxiaoyanhuang@aliyun.com., Iorio MV; Start Up Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marilena.iorio@istitutotumori.mi.it., Cataldo A; Start Up Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: alessandra.cataldo@istitutotumori.mi.it., Tagliabue E; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: elda.tagliabue@istitutotumori.mi.it., Daidone MG; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: mariagrazia.daidone@istitutotumori.mi.it., Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China. Electronic address: wujiong1122@vip.sina.com., Orlandi R; Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: rosaria.orlandi@istitutotumori.mi.it.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2018 Jun; Vol. 39, pp. 46-52. Date of Electronic Publication: 2018 Mar 26.
Autor:
Andriani F; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Majorini MT; Molecular Mechanisms of Cell Cycle Control Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mano M; Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.; Present Address: Functional Genomics and RNA-based Therapeutics laboratory, Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3060-197, Coimbra, Portugal., Landoni E; Unit of Medical Statistics, Biometry, and Bioinformatics Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Miceli R; Unit of Medical Statistics, Biometry, and Bioinformatics Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Facchinetti F; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mensah M; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fontanella E; Molecular Mechanisms of Cell Cycle Control Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Functional Genomics and Bioinformatics Core Facility, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giacca M; Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Pastorino U; Thoracic Surgery Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sozzi G; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Delia D; Molecular Mechanisms of Cell Cycle Control Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Roz L; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. luca.roz@istitutotumori.mi.it., Lecis D; Molecular Mechanisms of Cell Cycle Control Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it.; Present Address: Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2018 Mar 20; Vol. 11 (1), pp. 45. Date of Electronic Publication: 2018 Mar 20.
Autor:
Romeo P; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Colombo C; Division of Endocrine and Metabolic DiseasesIRCCS Istituto Auxologico Italiano, Milan, Italy.; Department of Pathophysiology and TransplantationUniversity of Milan, Milan, Italy., Granata R; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Calareso G; Department of RadiologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gualeni AV; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Functional Genomics and Bioinformatics UnitDepartment of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Functional Genomics and Bioinformatics UnitDepartment of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rizzetti MG; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Zanframundo A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Aiello A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Carcangiu ML; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gloghini A; Department of Diagnostic Pathology and Laboratory MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ferrero S; Department of Pathophysiology and TransplantationFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of BiomedicalSurgical and Dental Sciences, University of Milan, Milan, Italy., Licitra L; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Medical OncologyUniversity of Milan, Milan, Italy., Greco A; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fugazzola L; Division of Endocrine and Metabolic DiseasesIRCCS Istituto Auxologico Italiano, Milan, Italy.; Department of Pathophysiology and TransplantationUniversity of Milan, Milan, Italy., Locati LD; Department of Head and Neck Medical OncologyFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy mariagrazia.borrello@istitutotumori.mi.it laura.locati@istitutotumori.mi.it., Borrello MG; Molecular Mechanisms UnitResearch Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy mariagrazia.borrello@istitutotumori.mi.it laura.locati@istitutotumori.mi.it.
Publikováno v:
Endocrine-related cancer [Endocr Relat Cancer] 2018 Mar; Vol. 25 (3), pp. 217-231. Date of Electronic Publication: 2018 Jan 03.
Autor:
El Bezawy R; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Rihan.elbezawy@istitutotumori.mi.it., Cominetti D; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Denis.cominetti@istitutotumori.mi.it., Fenderico N; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: N.Fenderico@umcutrecht.nl., Zuco V; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Valentina.zuco@istitutotumori.mi.it., Beretta GL; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Giovanni.Beretta@istitutotumori.mi.it., Dugo M; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Matteo.dugo@istitutotumori.mi.it., Arrighetti N; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Noemi.arrighetti@istitutotumori.mi.it., Stucchi C; Unit of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Claudio.Stucchi@istitutotumori.mi.it., Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Tiziana.rancati@istitutotumori.mi.it., Valdagni R; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Riccardo.valdagni@istitutotumori.mi.it., Zaffaroni N; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: nadia.zaffaroni@istitutotumori.mi.it., Gandellini P; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy. Electronic address: Paolo.gandellini@istitutotumori.mi.it.
Publikováno v:
Cancer letters [Cancer Lett] 2017 Jun 01; Vol. 395, pp. 53-62. Date of Electronic Publication: 2017 Mar 06.
Autor:
Gimondi S; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Hematology, Department of Oncology and Onco-Hematology, Università degli Studi di Milano, Milan, Italy. Electronic address: silvia.gimondi@unimi.it., Dugo M; Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vendramin A; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Hematology, Department of Oncology and Onco-Hematology, Università degli Studi di Milano, Milan, Italy., Bermema A; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Biancon G; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cavané A; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Corradini P; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Hematology, Department of Oncology and Onco-Hematology, Università degli Studi di Milano, Milan, Italy., Carniti C; Department of Hematology and Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Experimental hematology [Exp Hematol] 2016 Jul; Vol. 44 (7), pp. 624-634.e1. Date of Electronic Publication: 2016 Mar 21.